☆ 4.7 Letter

Relationship among three common hematological premalignant conditions

LEUKEMIA (2023)

Related references

Note: Only part of the references are listed.

Article Oncology

Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans

Geffen Kleinstern et al.

Summary: This study found significant associations between 41 CLL susceptibility variants and CLL-PRS with MBL risk, while little evidence of any association between MBL risk and environmental factors was observed. The CLL-PRS showed significant associations with EA-CLL risk and AA-CLL risk, indicating the need for further research in this population.

LEUKEMIA (2022)

Add to Collection

Article Hematology

MGUS and clonal hematopoiesis show unrelated clinical and biological trajectories in an older population cohort

Matteo Claudio Da Via et al.

Summary: Monoclonal gammopathy of undetermined significance (MGUS) and clonal hematopoiesis (CH) are two preclinical clonal expansions of hematopoietic cells that increase with age. This study analyzed a dataset of 777 older subjects and found that the prevalence of MGUS and CH was 9.6% and 17.3% respectively, with no significant correlation between MGUS and CH.

BLOOD ADVANCES (2022)

Add to Collection

Article Hematology

Prevalence of heavy chain MGUS by race and family history risk groups using a high-sensitivity screening method

Celine M. Vachon et al.

Summary: Mass-spectrometry (MS) assays can detect monoclonal gammopathy of undetermined significance (MGUS) at an earlier stage, and the prevalence of heavy chain MGUS is higher in African Americans and first-degree relatives of patients with hematologic disorders. The MALDI-TOF assay can identify more cases of MGUS compared to conventional gel-based methods, but the relative differences based on race, family history, and age are similar to prior studies.

BLOOD ADVANCES (2022)

Add to Collection

Article Hematology

Progression and survival of MBL: a screening study of 10 139 individuals

Susan L. Slager et al.

Summary: Monoclonal B-cell lymphocytosis (MBL) is a common hematological premalignant condition that is associated with a fourfold increased risk of lymphoid malignancies in individuals with low-count MBL (LC-MBL).

BLOOD (2022)

Add to Collection

Review Oncology

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

Rita Alaggio et al.

Summary: This article provides an overview of the upcoming 5th edition of the World Health Organization classification of lymphoid tumors, highlighting changes from the previous edition such as reorganization of entities, modification of nomenclature, revision of diagnostic criteria, deletion of entities, introduction of new entities, and inclusion of tumor-like lesions.

LEUKEMIA (2022)

Add to Collection

Letter Oncology

Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL)

Tait D. Shanafelt et al.

LEUKEMIA (2021)

Add to Collection

Article Hematology

Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families

Susan L. Slager et al.

Summary: The study investigated the incidence and natural history of MBL in relatives from CLL families, finding that low-count MBL may precede progression to CLL with a higher transformation rate in these families. Furthermore, the study estimated an annual progression rate from low-count MBL to CLL that exceeds that in the general population.

BLOOD (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Distinction of lymphoid and myeloid clonal hematopoiesis

Abhishek Niroula et al.

Summary: Studies have shown that clonal hematopoiesis and mosaic chromosomal alterations are associated with lineage-specific hematologic malignancies, and these genetic alterations can be used in combination with blood count parameters to identify individuals at high risk.

NATURE MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection

Seyedeh M. Zekavat et al.

Summary: Research shows that mosaic chromosomal alterations in blood-derived DNA are associated with an increased risk of various infections, such as sepsis and pneumonia. These alterations may serve as markers of impaired immunity, leading to an increased predisposition to infections.

NATURE MEDICINE (2021)

Add to Collection

Article Hematology

Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance

Alyssa Clay-Gilmour et al.

BLOOD ADVANCES (2020)

Add to Collection

Article Multidisciplinary Sciences

Inherited causes of clonal haematopoiesis in 97,691 whole genomes

Alexander G. Bick et al.

NATURE (2020)

Add to Collection

Article Oncology

Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement

David Murray et al.

BLOOD CANCER JOURNAL (2019)

Add to Collection

Article Hematology

Hospital population screening reveals overrepresentation of CD5- monoclonal B-cell lymphocytosis and monoclonal gammopathy of undetermined significance of IgM type

Minna Voigtlaender et al.

ANNALS OF HEMATOLOGY (2015)

Add to Collection

Article Hematology

Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study

Sigurdur Y. Kristinsson et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)

Add to Collection

Article Medicine, General & Internal

A long-term study of prognosis in monoclonal gammopathy of undetermined significance

RA Kyle et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.